MEDANTA Q1 FY27 results at a glance
GLOBAL HEALTH LIMITED Q1 FY27 key results metrics| Quarter | Q1 FY27 |
|---|
| Quarter ended | 30 Jun 2026 |
|---|
| Revenue | ₹1,304 cr |
|---|
| Revenue YoY | +26.5% |
|---|
| Operating profit | ₹218 cr |
|---|
| Operating margin | 16.7% |
|---|
| Net profit | ₹159 cr |
|---|
| Net profit YoY | -0.2% |
|---|
| Net profit QoQ | +10.2% |
|---|
| Net margin | 12.2% |
|---|
| Basic EPS | ₹5.91 |
|---|
| TTM revenue | ₹4,683 cr |
|---|
| TTM net profit | ₹556 cr |
|---|
| TTM net margin | 11.9% |
|---|
MEDANTA Q1 FY27 results: what the numbers say
GLOBAL HEALTH LIMITED (MEDANTA) has reported its Q1 FY27 results for the quarter ended 2026-06-30. The company posted revenue of ₹1,304 cr and a net profit of ₹159 cr, translating into earnings per share of ₹5.91.
Compared with the same quarter a year earlier, revenue grew strongly by +26.5% and net profit declined marginally by -0.2%. Profit trailing revenue growth suggests costs, interest or tax absorbed part of the topline gain.
Operating profit for the quarter stood at ₹218 cr, an operating margin of 16.7% versus 17.6% a year ago — a contraction of 0.9 percentage points.
MEDANTA quarter-wise results table
Revenue
₹1,304 cr
+26.5% YoY
Net profit
₹159 cr
-0.2% YoY
Operating profit
₹218 cr
+19.7% YoY
GLOBAL HEALTH LIMITED (MEDANTA) quarter-wise results — revenue, operating profit, net profit, margins, EPS and growth| Quarter | Revenue | Operating profit | Net profit | OPM | Net margin | EPS | Profit YoY | Profit QoQ |
|---|
| Q1 FY272026-06-30 | ₹1,304 cr | ₹218 cr | ₹159 cr | 16.7% | 12.2% | ₹5.91 | -0.2% | +10.2% |
| Q4 FY262026-03-31 | ₹1,159 cr | ₹177 cr | ₹144 cr | 15.3% | 12.4% | ₹5.36 | — | +51.5% |
| Q3 FY262025-12-31 | ₹1,121 cr | ₹156 cr | ₹95.02 cr | 13.9% | 8.5% | ₹3.54 | — | -40.0% |
| Q2 FY262025-09-30 | ₹1,099 cr | ₹181 cr | ₹158 cr | 16.5% | 14.4% | ₹5.89 | — | -0.4% |
| Q1 FY262025-06-30 | ₹1,031 cr | ₹182 cr | ₹159 cr | 17.6% | 15.4% | ₹5.92 | — | — |
| TTM (last 4 quarters) | ₹4,683 cr | ₹732 cr | ₹556 cr | 15.6% | 11.9% | ₹20.70 | — | — |
Consolidated figures as reported to the exchanges, shown in ₹ crore. OPM = operating profit margin. Updated automatically whenever a new quarter is filed.
MEDANTA quarterly income statement
Line-item results for the last six quarters as filed — sales, expenses, operating profit, interest, tax and profit after tax in ₹ crore.
GLOBAL HEALTH LIMITED quarterly income statement| Particulars | Q1 FY272026-06-30 | Q4 FY262026-03-31 | Q3 FY262025-12-31 | Q2 FY262025-09-30 | Q1 FY262025-06-30 |
|---|
| Revenue / Sales | ₹1,304 cr | ₹1,159 cr | ₹1,121 cr | ₹1,099 cr | ₹1,031 cr |
|---|
| Total expenses | ₹1,086 cr | ₹982 cr | ₹965 cr | ₹918 cr | ₹849 cr |
|---|
| Gross profit | ₹1,010 cr | ₹913 cr | ₹865 cr | ₹844 cr | ₹792 cr |
|---|
| Operating profit (EBIT) | ₹218 cr | ₹177 cr | ₹156 cr | ₹181 cr | ₹182 cr |
|---|
| Operating margin | 16.7% | 15.3% | 13.9% | 16.5% | 17.6% |
|---|
| Interest cost | ₹26.68 cr | ₹26.71 cr | ₹21.51 cr | ₹17.11 cr | ₹13.79 cr |
|---|
| Profit before tax | ₹213 cr | ₹187 cr | ₹120 cr | ₹200 cr | ₹208 cr |
|---|
| Tax expense | ₹56.01 cr | ₹45.63 cr | ₹24.75 cr | ₹41.41 cr | ₹49.16 cr |
|---|
| Effective tax rate | 26.3% | 24.4% | 20.7% | 20.7% | 23.6% |
|---|
| Net profit (PAT) | ₹159 cr | ₹144 cr | ₹95.02 cr | ₹158 cr | ₹159 cr |
|---|
| Net profit margin | 12.2% | 12.4% | 8.5% | 14.4% | 15.4% |
|---|
| Basic EPS | ₹5.91 | ₹5.36 | ₹3.54 | ₹5.89 | ₹5.92 |
|---|
| Diluted EPS | ₹5.90 | ₹5.35 | ₹3.54 | ₹5.89 | ₹5.91 |
|---|
MEDANTA results growth — YoY and QoQ
Quarterly growth rates, year on year and quarter on quarter| Growth | Q1 FY27 | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 |
|---|
| Revenue YoY | +26.5% | — | — | — | — |
|---|
| Revenue QoQ | +12.5% | +3.4% | +2.0% | +6.6% | — |
|---|
| Operating profit YoY | +19.7% | — | — | — | — |
|---|
| Operating profit QoQ | +22.9% | +13.5% | -13.9% | -0.4% | — |
|---|
| Net profit YoY | -0.2% | — | — | — | — |
|---|
| Net profit QoQ | +10.2% | +51.5% | -40.0% | -0.4% | — |
|---|
| EPS YoY | -0.2% | — | — | — | — |
|---|
| EPS QoQ | +10.3% | +51.4% | -39.9% | -0.5% | — |
|---|
MEDANTA annual results history
Full-year performance for GLOBAL HEALTH LIMITED, useful for reading each quarter in context.
GLOBAL HEALTH LIMITED annual income statement| Particulars | FY262026-03-31 | FY252025-03-31 | FY242024-03-31 | FY232023-03-31 |
|---|
| Revenue / Sales | ₹4,318 cr | ₹3,637 cr | ₹3,241 cr | ₹2,683 cr |
|---|
| Total expenses | ₹3,592 cr | ₹2,900 cr | ₹2,583 cr | ₹2,184 cr |
|---|
| Gross profit | ₹3,322 cr | ₹2,757 cr | ₹2,482 cr | ₹2,058 cr |
|---|
| Operating profit (EBIT) | ₹727 cr | ₹737 cr | ₹658 cr | ₹499 cr |
|---|
| Operating margin | 16.8% | 20.3% | 20.3% | 18.6% |
|---|
| Interest cost | ₹78.04 cr | ₹64.02 cr | ₹72.54 cr | ₹77.46 cr |
|---|
| Profit before tax | ₹715 cr | ₹647 cr | ₹627 cr | ₹449 cr |
|---|
| Tax expense | ₹161 cr | ₹166 cr | ₹149 cr | ₹123 cr |
|---|
| Effective tax rate | 22.5% | 25.6% | 23.8% | 27.4% |
|---|
| Net profit (PAT) | ₹556 cr | ₹481 cr | ₹478 cr | ₹326 cr |
|---|
| Net profit margin | 12.9% | 13.2% | 14.8% | 12.2% |
|---|
| Basic EPS | ₹20.71 | ₹17.92 | ₹17.80 | ₹12.58 |
|---|
| Diluted EPS | ₹20.66 | ₹17.92 | ₹17.80 | ₹12.57 |
|---|
Revenue trend and demand read-through
Topline for Q1 FY27 came in at ₹1,304 cr against ₹1,031 cr in Q1 FY26, and ₹1,159 cr in the preceding Q4 FY26 quarter.
On a sequential basis revenue grew +12.5%. Sequential moves are the quickest read on demand momentum because they strip out the base effect of a year-old quarter, though seasonality can distort a single quarter.
Total expenses for the quarter were ₹1,086 cr, or 83.3% of revenue, with operating profit grew +19.7% year on year.
Margins, tax and profitability
Net profit of ₹159 cr works out to a net margin of 12.2% compared with 15.4% in the year-ago quarter. Margin pressure of this kind usually reflects higher input costs, pricing competition, or a heavier interest and depreciation load.
Below the operating line, GLOBAL HEALTH LIMITED reported profit before tax of ₹213 cr, a tax charge of ₹56.01 cr (effective rate 26.3%), interest cost of ₹26.68 cr. Reading these together with operating profit shows how much of the quarter's earnings were driven by the core business versus financing and tax movements.
Sequentially, net profit moved from ₹144 cr in Q4 FY26 to ₹159 cr in Q1 FY27, a change of +10.2%.
Trailing twelve months and annual context
Across the trailing four quarters GLOBAL HEALTH LIMITED has generated revenue of ₹4,683 cr and net profit of ₹556 cr, a trailing net margin of 11.9%. The trailing view smooths out one-off quarters and is the number most valuation multiples are built on.
On a full-year basis, FY26 revenue was ₹4,318 cr with net profit of ₹556 cr and EPS of ₹20.71, versus the prior year where revenue grew +18.7% and profit grew +15.6%.
What to watch in the next MEDANTA quarter
For the coming quarters the numbers worth tracking on this page are revenue momentum, the operating margin trend, the interest burden and whether EPS keeps pace with profit growth. A single weak quarter matters less than the direction over three to four consecutive quarters.
GLOBAL HEALTH LIMITED has not yet intimated its next results date to the exchange. This page refreshes automatically from filings and the board-meeting calendar, so the tables above will reflect the next quarter as soon as it is reported.
All figures here are as reported to the exchanges and shown in ₹ crore, without adjustment. This is information and analysis, not investment advice.
MEDANTA results coverage
No results report published for MEDANTA yet — our desk covers each quarter within minutes of the filing.
MEDANTA quarterly results FAQs
What were GLOBAL HEALTH LIMITED (MEDANTA) Q1 FY27 results?
In Q1 FY27 (quarter ended 30 Jun 2026), GLOBAL HEALTH LIMITED reported revenue of ₹1,304 cr and net profit of ₹159 cr, a change of -0.2% year on year on +26.5% revenue growth. EPS stood at ₹5.91.
What is MEDANTA profit margin in Q1 FY27?
GLOBAL HEALTH LIMITED posted a net profit margin of 12.2% and an operating margin of 16.7% in Q1 FY27. On a trailing twelve-month basis, revenue is ₹4,683 cr and net profit ₹556 cr.
Did MEDANTA results beat the previous quarter?
GLOBAL HEALTH LIMITED net profit changed +10.2% quarter on quarter, from ₹144 cr in Q4 FY26 to ₹159 cr in Q1 FY27.
When are GLOBAL HEALTH LIMITED (MEDANTA) quarterly results?
GLOBAL HEALTH LIMITED has not yet intimated its next results date to the exchange. This page updates automatically from the exchange board-meeting calendar.
Where can I see MEDANTA latest quarterly results?
Results coverage for MEDANTA will appear here as soon as the company reports. Meanwhile you can track live price and technicals on the MEDANTA stock page.
What is GLOBAL HEALTH LIMITED annual revenue and profit?
For FY26, GLOBAL HEALTH LIMITED reported full-year revenue of ₹4,318 cr and net profit of ₹556 cr, with EPS of ₹20.71.
How many quarterly results has MEDANTA declared recently?
Past results dates for MEDANTA will be listed here from the exchange calendar.
Results dates sourced from the exchange board-meeting calendar; reported figures from company filings, last refreshed 12 Sept 2026. For information only, not investment advice.
